Overview

Diclofenac Gel in the Treatment of Cervicogenic Headache

Status:
Not yet recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
The intervention will consist of the nursing staff applying 2 grams of diclofenac 1% gel topically to the posterior cervical region four times daily. The control group will receive petroleum jelly topically to the posterior cervical region four times daily. Patients will receive a pre-intervention and post-intervention survey incorporating the Numeric Assessment Scale and Headache Impact Test-6.
Phase:
Phase 3
Details
Lead Sponsor:
Loma Linda University
Treatments:
Diclofenac
Petrolatum